1. Home
  2. RCUS vs PWP Comparison

RCUS vs PWP Comparison

Compare RCUS & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • PWP
  • Stock Information
  • Founded
  • RCUS 2015
  • PWP 2006
  • Country
  • RCUS United States
  • PWP United States
  • Employees
  • RCUS N/A
  • PWP N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • PWP Finance: Consumer Services
  • Sector
  • RCUS Health Care
  • PWP Finance
  • Exchange
  • RCUS Nasdaq
  • PWP Nasdaq
  • Market Cap
  • RCUS 1.2B
  • PWP 1.3B
  • IPO Year
  • RCUS 2018
  • PWP N/A
  • Fundamental
  • Price
  • RCUS $13.90
  • PWP $20.24
  • Analyst Decision
  • RCUS Buy
  • PWP Hold
  • Analyst Count
  • RCUS 7
  • PWP 3
  • Target Price
  • RCUS $22.00
  • PWP $23.67
  • AVG Volume (30 Days)
  • RCUS 937.9K
  • PWP 801.8K
  • Earning Date
  • RCUS 11-05-2025
  • PWP 11-07-2025
  • Dividend Yield
  • RCUS N/A
  • PWP 1.37%
  • EPS Growth
  • RCUS N/A
  • PWP N/A
  • EPS
  • RCUS N/A
  • PWP 0.90
  • Revenue
  • RCUS $262,000,000.00
  • PWP $871,012,000.00
  • Revenue This Year
  • RCUS N/A
  • PWP $1.99
  • Revenue Next Year
  • RCUS N/A
  • PWP $25.18
  • P/E Ratio
  • RCUS N/A
  • PWP $22.68
  • Revenue Growth
  • RCUS 6.07
  • PWP 20.01
  • 52 Week Low
  • RCUS $6.50
  • PWP $14.12
  • 52 Week High
  • RCUS $18.98
  • PWP $27.03
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 68.53
  • PWP 37.52
  • Support Level
  • RCUS $12.89
  • PWP $20.18
  • Resistance Level
  • RCUS $16.12
  • PWP $21.92
  • Average True Range (ATR)
  • RCUS 0.73
  • PWP 0.81
  • MACD
  • RCUS 0.07
  • PWP -0.19
  • Stochastic Oscillator
  • RCUS 44.17
  • PWP 1.14

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

Share on Social Networks: